More about
Systemic Anca-Associated Vasculitis
News
June 14, 2023
2 min read
Save
Rituximab, cyclophosphamide show similar rates of kidney failure, death in AAV
Remission induction strategies based on rituximab and cyclophosphamide each demonstrate similar risks for kidney failure and death in patients with ANCA-associated vasculitis, according to data published in Arthritis & Rheumatology.
News
March 18, 2024
2 min watch
Save
VIDEO: Research in ANCA-associated vasculitis may bring a ‘big change in practice’
In this video, Fahmeedah Kamal, MD, discusses a current hot topic in vasculitis research.